GSK to move headquarters from Brentford to Weybridge

GSK is leaving its headquarters building in Brentford and moving out of London. The global pharmaceutical company, one of the five biggest employers in the borough of Hounslow, is set to move its commercial division to Weybridge in Surrey by the end of 2022, with their Research and Development and Vaccines Business remaining in the current premises in Brentford until 2023.

The company is separating itself into two. The new GSK will be a global pharmaceuticals and vaccines company with an R&D approach focused on the science of the immune system, human genetics and advanced technologies.

The other part of the company will become a world leading Consumer Healthcare company with annual sales of more than £10 billion, including nine global power brands. Both will be leading UK companies.

LB Hounslow say they will undertake an ‘extensive global search’ for an alternative occupier for the Great West Road site.

GSK’s plan, announced on Monday 11 October, include building a major new UK-based headquarters and global campus for the new Consumer Healthcare company following separation in 2022, and its long-term plan for the future headquarters of GSK.

The company expects to have staff at its current headquarters at GSK House beside the M4 until at least the end of 2023.

Major blow to Hounslow’s economy.

The loss of GSK is a major blow to the economy of the borough, already badly hit by the impact of Covid on Heathrow. GSK employs 17,000 people in the UK, at locations in London, Twickenham and Stevenage. 

Leader of Hounslow Council, Councillor Steve Curran, said:

“GSK have been a landmark presence and valued employer in our borough since 2002.  We understand their need to find more suitable accommodation to meet the needs of their new busines model and ways of working and will be working closely with them to mitigate the impact of the decision on the community at an already very difficult time.

“In conjunction with Ruth Cadbury MP, we will be working out the exact implications of this announcement, and the best ways to support everyone involved.  Renewing our local economies and supporting residents and businesses remains a continuing priority, which this announcement makes even more crucial.”

Member of Parliament for Brentford and Isleworth, Ruth Cadbury MP, said;

‘‘The news that GSK will be leaving their site on the Great West Road will have a huge impact on our local area. GSK are a major employer locally, and I know that many people rely on their Brentford site, both for their job and also for the wider investment it brings in for businesses locally.

This news comes at a time when Hounslow is facing a turbulent economic future due to the coronavirus pandemic, and decline in international aviation.

I will be meeting with GSK and working with Hounslow Council to ensure that local jobs are protected, and to support our local economy during this move.’’

Brian McNamara, CEO Designate, GSK Consumer Healthcare said:

“This investment in a new cutting-edge campus in the UK will bring together our first-in-class teams as we drive towards our ambitions as the world’s leading consumer healthcare company.

Today’s announcement is an important step as we prepare for separation, marking an exciting new beginning for New Consumer Healthcare.”

Read more stories on The Chiswick Calendar

See also: GSK Malaria vaccine approved for use across Africa

See also: Hounslow expecting a leap in unemployment as furlough ends

See all the latest stories: Chiswick Calendar News & Features

Support The Chiswick Calendar

The Chiswick Calendar CIC is a community resource. Please support us by buying us the equivalent of a monthly cup of coffee (or more, if you insist). Click here to support us.

We publish a weekly newsletter and update the website with local news and information daily. We are editorially independent.

To subscribe to the weekly newsletter, go here.